Capital Research Global Investors Amgen Inc Transaction History

Capital Research Global Investors

  • $463 Billion
  • Q3 2024

A detailed history of Capital Research Global Investors transactions in Amgen Inc stock. As of the latest transaction made, Capital Research Global Investors holds 4,050,406 shares of AMGN stock, worth $1.07 Billion. This represents 0.28% of its overall portfolio holdings.

Number of Shares
4,050,406
Previous 4,004,462 1.15%
Holding current value
$1.07 Billion
Previous $1.25 Billion 4.31%
% of portfolio
0.28%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$309.38 - $337.38 $14.2 Million - $15.5 Million
45,944 Added 1.15%
4,050,406 $1.31 Billion
Q2 2024

Aug 13, 2024
SELL
$262.75 - $319.31 $438 Million - $532 Million
-1,666,301 Reduced 29.38%
4,004,462 $1.25 Billion
Q1 2024

May 14, 2024
SELL
$268.87 - $324.56 $279 Million - $336 Million
-1,035,888 Reduced 15.45%
5,670,763 $1.61 Billion
Q4 2023

Feb 13, 2024
SELL
$255.7 - $288.46 $457 Million - $515 Million
-1,786,558 Reduced 21.04%
6,706,651 $1.93 Billion
Q3 2023

Nov 13, 2023
SELL
$218.65 - $271.46 $235 Million - $292 Million
-1,076,582 Reduced 11.25%
8,493,209 $2.28 Billion
Q2 2023

Aug 11, 2023
SELL
$214.27 - $253.37 $484 Million - $572 Million
-2,258,318 Reduced 19.09%
9,569,791 $2.12 Billion
Q1 2023

May 15, 2023
SELL
$225.79 - $275.2 $20.2 Million - $24.6 Million
-89,456 Reduced 0.75%
11,828,109 $2.86 Billion
Q4 2022

Feb 14, 2023
SELL
$229.03 - $291.01 $158 Million - $200 Million
-687,700 Reduced 5.46%
11,917,565 $3.13 Billion
Q3 2022

Nov 14, 2022
SELL
$224.46 - $253.15 $334 Million - $377 Million
-1,490,071 Reduced 10.57%
12,605,265 $2.84 Billion
Q2 2022

Aug 15, 2022
SELL
$230.71 - $256.74 $1 Billion - $1.11 Billion
-4,336,215 Reduced 23.53%
14,095,336 $3.43 Billion
Q1 2022

May 16, 2022
SELL
$219.27 - $242.57 $817 Million - $904 Million
-3,726,355 Reduced 16.82%
18,431,551 $4.46 Billion
Q4 2021

Feb 14, 2022
SELL
$198.88 - $227.6 $908 Million - $1.04 Billion
-4,566,275 Reduced 17.09%
22,157,906 $4.98 Billion
Q3 2021

Nov 15, 2021
SELL
$212.27 - $248.7 $549 Million - $643 Million
-2,586,436 Reduced 8.82%
26,724,181 $5.68 Billion
Q2 2021

Aug 16, 2021
SELL
$233.58 - $259.14 $773 Million - $857 Million
-3,307,947 Reduced 10.14%
29,310,617 $7.14 Billion
Q1 2021

May 14, 2021
BUY
$221.91 - $258.6 $190 Million - $221 Million
856,237 Added 2.7%
32,618,564 $8.12 Billion
Q4 2020

Feb 12, 2021
SELL
$216.38 - $257.67 $376 Million - $448 Million
-1,738,686 Reduced 5.19%
31,762,327 $7.3 Billion
Q3 2020

Nov 13, 2020
BUY
$234.65 - $260.95 $32.7 Million - $36.4 Million
139,339 Added 0.42%
33,501,013 $8.51 Billion
Q2 2020

Aug 14, 2020
BUY
$197.81 - $242.74 $49.7 Million - $60.9 Million
251,029 Added 0.76%
33,361,674 $7.87 Billion
Q1 2020

May 15, 2020
SELL
$182.24 - $241.7 $406 Million - $538 Million
-2,226,994 Reduced 6.3%
33,110,645 $6.71 Billion
Q4 2019

Feb 18, 2020
BUY
$189.21 - $243.2 $330 Million - $424 Million
1,743,084 Added 5.19%
35,337,639 $8.52 Billion
Q3 2019

Nov 14, 2019
BUY
$174.11 - $208.62 $703 Million - $842 Million
4,036,798 Added 13.66%
33,594,555 $6.5 Billion
Q2 2019

Aug 14, 2019
SELL
$166.7 - $195.41 $640 Million - $750 Million
-3,836,745 Reduced 11.49%
29,557,757 $5.45 Billion
Q1 2019

May 15, 2019
SELL
$180.87 - $203.88 $317 Million - $357 Million
-1,750,473 Reduced 4.98%
33,394,502 $6.34 Billion
Q4 2018

Feb 14, 2019
BUY
$178.4 - $208.25 $129 Million - $150 Million
722,277 Added 2.1%
35,144,975 $6.84 Billion
Q3 2018

Nov 14, 2018
SELL
$185.29 - $208.89 $2.13 Billion - $2.41 Billion
-11,515,778 Reduced 25.07%
34,422,698 $7.14 Billion
Q2 2018

Aug 14, 2018
SELL
$166.05 - $186.51 $182 Million - $204 Million
-1,096,159 Reduced 2.33%
45,938,476 $8.48 Billion
Q1 2018

May 15, 2018
SELL
$169.43 - $198.0 $659 Million - $770 Million
-3,888,105 Reduced 7.64%
47,034,635 $8.02 Billion
Q4 2017

Feb 14, 2018
SELL
$168.79 - $188.59 $263 Million - $294 Million
-1,559,732 Reduced 2.97%
50,922,740 $8.86 Billion
Q3 2017

Nov 14, 2017
BUY
$167.29 - $191.0 $8.78 Billion - $10 Billion
52,482,472
52,482,472 $9.79 Billion

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email